Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer

We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who re...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 11; p. 640846
Main Authors Zhang, Jingjing, Cao, Dongyan, Yang, Jiaxin, Shen, Keng, He, Yonglan, Xue, Huadan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.04.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm 3 , respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm 3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm 3 ), which could be an indication of initial chemoradiotherapy for early cervical cancer.
AbstractList We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm 3 , respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm 3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm 3 ), which could be an indication of initial chemoradiotherapy for early cervical cancer.
We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm , respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm ), which could be an indication of initial chemoradiotherapy for early cervical cancer.
We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student’s t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01–13.5 mm and 105–27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer.
We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer.We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored the predictive value of these parameters for different types of risk patients to guide individualized therapeutic strategies. Patients who received the initial treatment of radical operation of cervical cancer and their postoperative pathological reports in our hospital from July 1, 2017, to June 30, 2019, were reviewed. Their minimum tumor-free margin and tumor volume were measured on preoperative magnetic resonance imaging. Student's t-test and the receiver operating characteristic curve analysis were used for data analysis. A total of 240 patients were included. Adverse pathological risk factors were as follows: deep cervical infiltration, 95 (39.6%) cases; lymph vascular space invasion, 91 (37.9%); lymph node metastasis, 20 (8.3%); parametrial infiltration, 8 (3.3%); tumor diameter ≥4 cm, 7 (2.9%); and positive surgical margin, 1 (0.4%). According to the adverse pathological factors, there were 20 (8.3%) high-risk patients, 50 (20.8%) medium-risk patients, and 170 (70.8%) low-risk patients. The ranges of the minimum tumor-free margin and tumor volume were 0.01-13.5 mm and 105-27,990 mm3, respectively. The minimum tumor-free margin with lymph node metastasis was significantly smaller than that without (P <0.05). The tumor volume with parametrial infiltration, deep cervical infiltration, or lymph vascular space invasion was significantly greater than that without (P < 0.05). The tumor volume was significantly different among low-, medium-, and high-risk patients (P <0.05). Tumor volume was of predictive value for high-risk patients (P < 0.05). With 3,505 mm3 as the cutoff value, the sensitivity and specificity for the prediction of high-risk patients were 88.9% and 84.8%, respectively. Tumor volume can be used as a great predictor of high-risk patients (cutoff value, 3,505 mm3), which could be an indication of initial chemoradiotherapy for early cervical cancer.
Author Zhang, Jingjing
Yang, Jiaxin
Shen, Keng
Cao, Dongyan
Xue, Huadan
He, Yonglan
AuthorAffiliation 2 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
3 Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
1 Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , China
AuthorAffiliation_xml – name: 1 Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen University , Guangzhou , China
– name: 2 Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
– name: 3 Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Jingjing
  surname: Zhang
  fullname: Zhang, Jingjing
– sequence: 2
  givenname: Dongyan
  surname: Cao
  fullname: Cao, Dongyan
– sequence: 3
  givenname: Jiaxin
  surname: Yang
  fullname: Yang, Jiaxin
– sequence: 4
  givenname: Keng
  surname: Shen
  fullname: Shen, Keng
– sequence: 5
  givenname: Yonglan
  surname: He
  fullname: He, Yonglan
– sequence: 6
  givenname: Huadan
  surname: Xue
  fullname: Xue, Huadan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33987083$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1r3DAQhkVJadI0956Kj714o2_Zl0JZ0mQh0FDS0psYfXhXqdfaSnZg_33lbhKSQuciMfPOM0LzvkVHQxw8Qu8JXjDWtOddHOyCYkoWkuOGy1fohFLG65azn0fP7sfoLOc7XEIKTDB7g44ZaxuFG3aC1rfTNqbqR-ynra9uknfBjrm6CutN_S3kX9UNjMEPJQWDqy6n4HyuVkMYA_TVcuNLM7gQx41PsNtXXWFdQOr31dKn-2BnEQzWp3fodQd99mcP5yn6_uXidnlVX3-9XC0_X9eWSzrWXEklrbScUEsJxQ4ctEZYwMp2nQRjhOMtpo0CoxpPVSkQwzrTUS6MlewUrQ5cF-FO71LYQtrrCEH_TcS01pDGYHuvwanGgHWsBBdOgXCdAmuAYcEEs4X16cDaTWbrnS3fkKB_AX1ZGcJGr-O9bgghuBEF8PEBkOLvyedRb0O2vu9h8HHKmgraEKVaSYv0w_NZT0MeN1UE-CCwKeacfPckIVjPftCzH_TsB33wQ2mR_7TYMJZ1xvm1of9_4x-_Gbyq
CitedBy_id crossref_primary_10_1186_s41205_025_00256_z
crossref_primary_10_3389_fonc_2021_690275
Cites_doi 10.1016/s0140-6736(97)02250-2
10.1097/IGC.0b013e3182a16997
10.7150/jca.50752
10.1136/ijgc-2019-000890
10.1093/jrr/rraa004
10.1016/j.ijgo.2009.02.009
10.1111/jog.13282
10.3857/roj.2012.30.2.70
10.1159/000353899
10.1016/S0959-8049(01)00353-7
10.1002/ijgo.12611
10.1097/igc.0000000000001327
10.6004/jnccn.2019.0001
10.3322/caac.20107
10.1016/s0140-6736(18)32470-x
10.1006/gyno.2001.6267
10.1007/s11912-017-0614-5
10.1006/gyno.2001.6493
10.1097/igc.0000000000001216
ContentType Journal Article
Copyright Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue.
Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue 2021 Zhang, Cao, Yang, Shen, He and Xue
Copyright_xml – notice: Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue.
– notice: Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue 2021 Zhang, Cao, Yang, Shen, He and Xue
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fonc.2021.640846
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList CrossRef
PubMed


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID oai_doaj_org_article_ad78bacd333345d7a5df7acba305353c
PMC8111085
33987083
10_3389_fonc_2021_640846
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-47676c6c412c2120dada9b5ca07cff6abb5d490287ab78e27a071b3fbf245bc63
IEDL.DBID M48
ISSN 2234-943X
IngestDate Wed Aug 27 00:47:49 EDT 2025
Thu Aug 21 14:04:35 EDT 2025
Fri Jul 11 01:50:39 EDT 2025
Thu Apr 03 07:05:42 EDT 2025
Tue Jul 01 04:38:44 EDT 2025
Thu Apr 24 22:59:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords adverse pathological risk factor
predictive value
tumor volume
cervical cancer
tumor-free margin
high-risk patients
Language English
License Copyright © 2021 Zhang, Cao, Yang, Shen, He and Xue.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-47676c6c412c2120dada9b5ca07cff6abb5d490287ab78e27a071b3fbf245bc63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Alberto Farolfi, Istituto Scientifico Romagnolo per lo Studio e il Trattamento dei Tumori (IRCCS), Italy
This article was submitted to Gynecological Oncology, a section of the journal Frontiers in Oncology
Reviewed by: Patrice Mathevet, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland; Benedetta Guani, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2021.640846
PMID 33987083
PQID 2528177962
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_ad78bacd333345d7a5df7acba305353c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8111085
proquest_miscellaneous_2528177962
pubmed_primary_33987083
crossref_primary_10_3389_fonc_2021_640846
crossref_citationtrail_10_3389_fonc_2021_640846
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-04-27
PublicationDateYYYYMMDD 2021-04-27
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-27
  day: 27
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in oncology
PublicationTitleAlternate Front Oncol
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Dostalek (B10) 2020; 30
Chen (B11) 2002; 23
Jemal (B2) 2011; 61
Zhu (B16) 2020; 11
Pecorelli (B3) 2009; 105
Bhatla (B4) 2018; 143
Landoni (B8) 1997; 350
Takekuma (B9) 2017; 43
Chen (B12) 2018; 28
Zigras (B14) 2017; 19
Byun (B13) 2013; 23
Covens (B17) 2002; 84
Koh (B7) 2019; 17
Wagenaar (B5) 2001; 82
Kim (B19) 2012; 30
Cibula (B6) 2018; 28
Cohen (B1) 2019; 393
Yamamoto (B15) 2020; 61
Meirovitz (B18) 2013; 76
References_xml – volume: 350
  year: 1997
  ident: B8
  article-title: Randomised Study of Radical Surgery Versus Radiotherapy for Stage Ib-Iia Cervical Cancer
  publication-title: Lancet
  doi: 10.1016/s0140-6736(97)02250-2
– volume: 23
  year: 2013
  ident: B13
  article-title: Three-Dimensional Transvaginal Ultrasonography for Locally Advanced Cervical Cancer
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/IGC.0b013e3182a16997
– volume: 11
  year: 2020
  ident: B16
  article-title: The Clinical and Prognostic Implication of Deep Stromal Invasion in Cervical Cancer Patients Undergoing Radical Hysterectomy
  publication-title: J Cancer
  doi: 10.7150/jca.50752
– volume: 30
  year: 2020
  ident: B10
  article-title: Oncologic Outcome After Completing or Abandoning (Radical) Hysterectomy in Patients With Cervical Cancer and Intraoperative Detection of Lymph Node Positivity; ABRAX (Abandoning Rad Hyst in Cervix Cancer)
  publication-title: Int J Gynecol Cancer
  doi: 10.1136/ijgc-2019-000890
– volume: 61
  year: 2020
  ident: B15
  article-title: Clinical Experience of Pelvic Radiotherapy or Chemoradiotherapy for Postoperative Uterine Cervical Cancer Using Intensity-Modulated Radiation Therapy
  publication-title: J Radiat Res
  doi: 10.1093/jrr/rraa004
– volume: 105
  year: 2009
  ident: B3
  article-title: Revised FIGO Staging for Carcinoma of the Cervix
  publication-title: Int J Gynaecol Obstet
  doi: 10.1016/j.ijgo.2009.02.009
– volume: 43
  year: 2017
  ident: B9
  article-title: The Issues Regarding Postoperative Adjuvant Therapy and Prognostic Risk Factors for Patients With Stage I-II Cervical Cancer: A Review
  publication-title: J Obstet Gynaecol Res
  doi: 10.1111/jog.13282
– volume: 30
  year: 2012
  ident: B19
  article-title: Method of Tumor Volume Evaluation Using Magnetic Resonance Imaging for Outcome Prediction in Cervical Cancer Treated With Concurrent Chemotherapy and Radiotherapy
  publication-title: Radiat Oncol J
  doi: 10.3857/roj.2012.30.2.70
– volume: 76
  year: 2013
  ident: B18
  article-title: Is Radical Hysterectomy Necessary in Early Cervical Cancer
  publication-title: Gynecol Obstet Invest
  doi: 10.1159/000353899
– volume: 23
  year: 2002
  ident: B11
  article-title: Correlation of Three-Dimensional Tumor Volumetry With Cervical Cancer Prognostic Parameters
  publication-title: Eur J Gynaecol Oncol
  doi: 10.1016/S0959-8049(01)00353-7
– volume: 143
  start-page: 22
  year: 2018
  ident: B4
  article-title: Cancer of the Cervix Uteri
  publication-title: Int J Gynaecol Obstet
  doi: 10.1002/ijgo.12611
– volume: 28
  year: 2018
  ident: B12
  article-title: Tumor Size At Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/igc.0000000000001327
– volume: 17
  start-page: 64
  year: 2019
  ident: B7
  article-title: Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
  publication-title: J Natl Compr Canc Netw
  doi: 10.6004/jnccn.2019.0001
– volume: 61
  start-page: 69
  year: 2011
  ident: B2
  article-title: Global Cancer Statistics
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.20107
– volume: 393
  year: 2019
  ident: B1
  article-title: Cervical Cancer
  publication-title: Lancet
  doi: 10.1016/s0140-6736(18)32470-x
– volume: 82
  year: 2001
  ident: B5
  article-title: Tumor Diameter and Volume Assessed by Magnetic Resonance Imaging in the Prediction of Outcome for Invasive Cervical Cancer
  publication-title: Gynecol Oncol
  doi: 10.1006/gyno.2001.6267
– volume: 19
  start-page: 51
  year: 2017
  ident: B14
  article-title: Early Cervical Cancer: Current Dilemmas of Staging and Surgery
  publication-title: Curr Oncol Rep
  doi: 10.1007/s11912-017-0614-5
– volume: 84
  year: 2002
  ident: B17
  article-title: How Important is Removal of the Parametrium At Surgery for Carcinoma of the Cervix
  publication-title: Gynecol Oncol
  doi: 10.1006/gyno.2001.6493
– volume: 28
  year: 2018
  ident: B6
  article-title: The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
  publication-title: Int J Gynecol Cancer
  doi: 10.1097/igc.0000000000001216
SSID ssj0000650103
Score 2.2782834
Snippet We evaluated the relationship between the minimum tumor-free margin, tumor volume, and adverse pathological risk factors in early cervical cancer and explored...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 640846
SubjectTerms adverse pathological risk factor
cervical cancer
high-risk patients
Oncology
predictive value
tumor volume
tumor-free margin
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqHlAviEKB8JKReuGQ7sbvHKGiFKRWFWpRb5afsAKyaLN76L9nJk5XuxWCCznGTmJ5vow_a8bfEHIoDIsc_qQ6Ji5r4XWo2xxMrXyTW5EMggqzLc7V6ZX4dC2vN0p9YU5YkQcuEzdxURvvQuRwCRm1kzFrF7zjqEzCA3pfWPM2NlPFB0ssYFDikrALayd53qFiIWuOlJga5Lsb69Ag1_8njnk3VXJj7Tl5QO6PpJG-LYPdJzupe0junY1h8Ufk6-Xq53xBvwyehl4ssGHZU8zhqD_P-u_0oqin9tR1kX5YzWLq6UdMG4K3omQA4CDOxrNYNxR4LB2Ej-nx4EmwE4JjcUCuTt5fHp_WYwWFOgjFlrXQSquggmhYgDVqGl10rZfBTXXIWTnvZRSo36Kd1yYxDQ2N59lnJqQPij8mu928S08JbRJwMQ90RKkosD4H-Aank5A8Bw2ktyKT2_m0YZQXxyoXPyxsM9ACFi1g0QK2WKAib9ZP_CrSGn_p-w5NtO6HotjDDYCKHaFi_wWViry-NbCFnwgjI65L81VvmWSm0bpVrCJPisHXn-K8BZ9meEX0FhS2xrLd0s2-DULdpsFDFvLZ_xj8c7KH84GBLKZfkN3lYpVeAh9a-lcD9H8DLDUKdQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Tumor Volume Predicts High-Risk Patients and Guides Initial Chemoradiotherapy for Early Cervical Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/33987083
https://www.proquest.com/docview/2528177962
https://pubmed.ncbi.nlm.nih.gov/PMC8111085
https://doaj.org/article/ad78bacd333345d7a5df7acba305353c
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkapeEG_Mo1okLhzcxvt0DghBRVuQiirUoNxW-2wjit3aiUT_PTO2EwiKOJCDD9ld29p5e2a_IeS1KFngIEl5iFzmwmmfj5Mvc-WKNBaxRKbCaosv6ngiPk_l9Pfx6GED242hHfaTmjSXez-vb96BwL_FiBPs7X6qKwQjZMWeEiOwp7fJHbBLGvsZnAzOfq-XJTY16HOVGxfukG3OIQgflXzNTHVo_ptc0L8rKf8wTYf3yN3Bp6Tveya4T27F6gHZPhmy5g_J-dniR93Qb50ioqcNDsxbiiUe-ddZ-52e9uCqLbVVoEeLWYgt_YRVRXBXRBQANgmz4ajWDQU3l3a4yPSgUzQ4CXmneUQmhx_PDo7zocFC7oVi81xopZVXXhTMgwkbBRvs2ElvR9qnpKxzMgiEd9HW6TIyDQOF48klJqTzij8mW1VdxaeEFhFcNQfeilJBYPsOUB1WRyF58hp84ozsL_fT-AF9HJtgXBqIQpAYBolhkBimJ0ZG3qxWXPXIG_-Y-wFJtJqHmNndH3VzbgYRNDbo0lkfOPyEDNrKkLT1znLEuOE-I6-WBDYgY5g4sVWsF61hkpWF1mPFMvKkJ_jqUUuGyYheY4W1d1kfqWYXHY53WeAZDPnsv1c-Jzu4CZjcYvoF2Zo3i_gSfKS52-2-LcD1aFrsdmLwCzRSE4I
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tumor+Volume+Predicts+High-Risk+Patients+and+Guides+Initial+Chemoradiotherapy+for+Early+Cervical+Cancer&rft.jtitle=Frontiers+in+oncology&rft.au=Zhang%2C+Jingjing&rft.au=Cao%2C+Dongyan&rft.au=Yang%2C+Jiaxin&rft.au=Shen%2C+Keng&rft.date=2021-04-27&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=11&rft_id=info:doi/10.3389%2Ffonc.2021.640846&rft_id=info%3Apmid%2F33987083&rft.externalDocID=PMC8111085
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon